New Vaccine Approach May Boost Immunity Longevity

Researchers identify potential way to generate longer-lasting T cell immunity against respiratory viruses.

Apr. 1, 2026 at 4:04am

Got story updates? Submit your updates here. ›

Researchers at the University of Wisconsin School of Veterinary Medicine have discovered a mechanism that could lead to the development of longer-lasting vaccines for respiratory viruses like influenza and COVID-19. The study, published in Cell Reports, focuses on T cells, which recognize more stable parts of viruses and offer broader protection compared to antibodies. The researchers found that triggering a bacterial-like inflammatory response, rather than a viral one, can lead to the creation of stem-like T cells that are more durable and adaptable when confronted with an infection.

Why it matters

Current vaccines often require regular boosters to maintain effectiveness as viruses mutate. The ability to generate longer-lasting T cell immunity could reduce the need for frequent vaccinations and provide broader protection against new variants, potentially improving public health outcomes and reducing vaccination fatigue.

The details

The researchers used an experimental vaccine approach in mice to compare two types of early immune signals: one that mimics a viral infection and another that resembles a bacterial response. They found that the viral-like inflammation caused memory T cells to quickly drop off, while the bacterial-like inflammation led to the development of a different type of memory T cell that persisted longer and provided better protection. These longer-lasting cells had characteristics similar to stem cells, including the ability to adapt when confronted with a virus.

  • The study was published on March 25, 2026 in the journal Cell Reports.
  • The research was funded by the National Institutes of Health (U01 AI124299 and R21 AI149793).

The players

M. Suresh

A professor in the Department of Pathobiological Sciences at the University of Wisconsin School of Veterinary Medicine who led the study.

University of Wisconsin School of Veterinary Medicine

The institution where the research was conducted.

Got photos? Submit your photos here. ›

What they’re saying

“We have discovered essentially a mechanism which we can target — a new clue to generating long-lived T cells.”

— M. Suresh, Professor

“So, what do we do? We need a plan B.”

— M. Suresh, Professor

“With the pandemic we went through, people are just tired of getting vaccinated.”

— M. Suresh, Professor

“They go and hunt one infected cell at a time and eliminate them.”

— M. Suresh, Professor

“But the problem is they don't stay very long. They die off, and we still don't know why.”

— M. Suresh, Professor

What’s next

The researchers plan to test the approach in nonhuman primates and in models that better reflect the diversity of human immune systems. Future work will also explore ways to guide immune cells to the lungs after traditional vaccination, which could improve protection without requiring new delivery methods.

The takeaway

This research offers a potential path toward vaccines that require fewer boosters and provide broader protection across variants, which could help address vaccination fatigue and improve public health outcomes for respiratory diseases.